Clinical Schizophrenia & Related Psychoses

Google Scholar citation report

Citations : 6601

Clinical Schizophrenia & Related Psychoses received 6601 citations as per Google Scholar report

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

	2022	2021	2020	2019	2018
Year wise published articles	105	141	28	8	28
Year wise citations received	543	553	590	563	587

Journal total citations count	6601
Journal Impact Factor	6.49
Journal 5 years Impact Factor	12.17
Journal CiteScore	11.19
Journal h-index	41
Journal h-index since 2016	26

Li, HuaFang, Ibrahim Turkoz, and Fan Zhang. "Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study." Neuropsychiatric disease and treatment 12 (2016): 15. View at Publisher View at Google Scholar View at Indexing
González-Rodríguez, Alexandre, Rosa Catalán, Rafael Penadés, Clemente Garcia-Rizo, Miquel Bioque, Eduard Parellada, and Miquel Bernardo. "Profile of paliperidone palmitate once-monthly long-acting injectable in the management of schizophrenia: long-term safety, efficacy, and patient acceptability–a review." Patient preference and adherence 9 (2015): 695. View at Publisher View at Google Scholar View at Indexing
Cano-Baena, Ana Isabel, Laura García-Ayala, Marta Zubía-Martín, Iñaki Zorrilla-Martínez, and Ana González-Pinto Arrillaga. "Schizophrenia and Gender." In Psychopathology in Women, pp. 715-737. Springer, Cham, 2019. View at Publisher View at Google Scholar View at Indexing
Correll, Christoph U., Robert E. Litman, Yuriy Filts, Jordi Llaudó, Dieter Naber, Ferran Torres, and Javier Martínez. "Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation." npj Schizophrenia 6, no. 1 (2020): 1-9. View at Publisher View at Google Scholar View at Indexing
Citrome, Leslie. "Long-acting injectable antipsychotics: what, when, and how." CNS spectrums 26, no. 2 (2021): 118-129. View at Publisher View at Google Scholar View at Indexing
Janicak, Philip G. "Acute management of schizophrenia." In Schizophrenia, pp. 107-138. Springer, New York, NY, 2014. View at Publisher View at Google Scholar View at Indexing
Clark, Ivana, and David Taylor. "Newer formulations of risperidone: role in the management of psychotic disorders." CNS drugs 34 (2020): 841-852. View at Publisher View at Google Scholar View at Indexing
Suzuki, Takefumi. "A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal." Expert opinion on drug delivery 13, no. 2 (2016): 253-264. View at Publisher View at Google Scholar View at Indexing
Cummings, Michael A., George J. Proctor, and Ai-Li W. Arias. "Dopamine antagonist antipsychotics in diverted forensic populations." CNS spectrums 25, no. 2 (2020): 128-135. View at Publisher View at Google Scholar View at Indexing
Hodgetts, Sophie, and Markus Hausmann. "Antipsychotic effects of sex hormones and atypical hemispheric asymmetries." Cortex 127 (2020): 313-332. View at Publisher View at Google Scholar View at Indexing
Chue, Pierre. "Risperidone long-acting injection." (2016). View at Publisher View at Google Scholar View at Indexing
Citrome, Leslie, and Jan Volavka. "Specific anti-hostility effects of atypical antipsychotics in persons with schizophrenia: from clozapine to cariprazine." Harvard review of psychiatry 29, no. 1 (2021): 20-34. View at Publisher View at Google Scholar View at Indexing
Peters, Luisa, Amanda Krogmann, Laura von Hardenberg, Katja Bödeker, Viktor B. Nöhles, and Christoph U. Correll. "Long-acting injections in schizophrenia: a 3-year update on randomized controlled trials published January 2016–March 2019." Current psychiatry reports 21, no. 12 (2019): 1-31. View at Publisher View at Google Scholar View at Indexing
Hodgetts, Sophie, and Markus Hausmann. "Antipsychotic effects of sex hormones and atypical hemispheric asymmetries." Cortex 127 (2020): 313-332. View at Publisher View at Google Scholar View at Indexing
Orsolini, Laura, Domenico De Berardis, and Umberto Volpe. "Up-to-date expert opinion on the safety of recently developed antipsychotics." Expert Opinion on Drug Safety 19, no. 8 (2020): 981-998. View at Publisher View at Google Scholar View at Indexing
Sentissi, Othman, Maria A. Andreou, Clotilde Moeglin, Logos Curtis, and Micaela Santos Brosch. "Psychosis Risk Syndrome: What Now?." Journal of Psychiatric Practice® 23, no. 6 (2017): 415-424. View at Publisher View at Google Scholar View at Indexing
de Leon, Jose. "Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics." Neuropharmacology 168 (2020): 107656. View at Publisher View at Google Scholar View at Indexing
Schoretsanitis, Georgios, John M. Kane, Christoph U. Correll, Stephen R. Marder, Leslie Citrome, John W. Newcomer, Delbert G. Robinson et al. "Blood levels to optimize antipsychotic treatment in clinical practice: a joint consensus statement of the American society of clinical psychopharmacology and the therapeutic drug monitoring task force of the arbeitsgemeinschaft für neuropsychopharmakologie und pharmakopsychiatrie." The Journal of Clinical Psychiatry 81, no. 3 (2020): 0-0. View at Publisher View at Google Scholar View at Indexing
Miyamoto, Seiya, and W. Wolfgang Fleischhacker. "The use of long-acting injectable antipsychotics in schizophrenia." Current treatment options in psychiatry 4, no. 2 (2017): 117-126. View at Publisher View at Google Scholar View at Indexing
Onaolapo, A. Y., and O. J. Onaolapo. "Schizophrenia aetiology and drug therapy: A tale of progressive demystification and strides in management." Adv Pharmacol Pharm 6, no. 2 (2018): 19-42. View at Publisher View at Google Scholar View at Indexing
Prev 1 2 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 Next »

Google Scholar citation report

Citations : 6601

Clinical Schizophrenia & Related Psychoses peer review process verified at publons

Indexed In

PMC/PubMed Indexed Articles

Citations Report

Clinical Schizophrenia & Related Psychoses : Citations & Metrics Report

Li, HuaFang, Ibrahim Turkoz, and Fan Zhang. "Efficacy and safety of once-monthly injection of paliperidone palmitate in hospitalized Asian patients with acute exacerbated schizophrenia: an open-label, prospective, noncomparative study." Neuropsychiatric disease and treatment 12 (2016): 15.

Cano-Baena, Ana Isabel, Laura García-Ayala, Marta Zubía-Martín, Iñaki Zorrilla-Martínez, and Ana González-Pinto Arrillaga. "Schizophrenia and Gender." In Psychopathology in Women, pp. 715-737. Springer, Cham, 2019.

Correll, Christoph U., Robert E. Litman, Yuriy Filts, Jordi Llaudó, Dieter Naber, Ferran Torres, and Javier Martínez. "Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation." npj Schizophrenia 6, no. 1 (2020): 1-9.

Citrome, Leslie. "Long-acting injectable antipsychotics: what, when, and how." CNS spectrums 26, no. 2 (2021): 118-129.

Janicak, Philip G. "Acute management of schizophrenia." In Schizophrenia, pp. 107-138. Springer, New York, NY, 2014.

Clark, Ivana, and David Taylor. "Newer formulations of risperidone: role in the management of psychotic disorders." CNS drugs 34 (2020): 841-852.

Suzuki, Takefumi. "A further consideration on long-acting injectable versus oral antipsychotics in the treatment of schizophrenia: a narrative review and critical appraisal." Expert opinion on drug delivery 13, no. 2 (2016): 253-264.

Cummings, Michael A., George J. Proctor, and Ai-Li W. Arias. "Dopamine antagonist antipsychotics in diverted forensic populations." CNS spectrums 25, no. 2 (2020): 128-135.

Hodgetts, Sophie, and Markus Hausmann. "Antipsychotic effects of sex hormones and atypical hemispheric asymmetries." Cortex 127 (2020): 313-332.

Chue, Pierre. "Risperidone long-acting injection." (2016).

Citrome, Leslie, and Jan Volavka. "Specific anti-hostility effects of atypical antipsychotics in persons with schizophrenia: from clozapine to cariprazine." Harvard review of psychiatry 29, no. 1 (2021): 20-34.

Peters, Luisa, Amanda Krogmann, Laura von Hardenberg, Katja Bödeker, Viktor B. Nöhles, and Christoph U. Correll. "Long-acting injections in schizophrenia: a 3-year update on randomized controlled trials published January 2016–March 2019." Current psychiatry reports 21, no. 12 (2019): 1-31.

Hodgetts, Sophie, and Markus Hausmann. "Antipsychotic effects of sex hormones and atypical hemispheric asymmetries." Cortex 127 (2020): 313-332.

Orsolini, Laura, Domenico De Berardis, and Umberto Volpe. "Up-to-date expert opinion on the safety of recently developed antipsychotics." Expert Opinion on Drug Safety 19, no. 8 (2020): 981-998.

Sentissi, Othman, Maria A. Andreou, Clotilde Moeglin, Logos Curtis, and Micaela Santos Brosch. "Psychosis Risk Syndrome: What Now?." Journal of Psychiatric Practice® 23, no. 6 (2017): 415-424.

de Leon, Jose. "Personalizing dosing of risperidone, paliperidone and clozapine using therapeutic drug monitoring and pharmacogenetics." Neuropharmacology 168 (2020): 107656.

Miyamoto, Seiya, and W. Wolfgang Fleischhacker. "The use of long-acting injectable antipsychotics in schizophrenia." Current treatment options in psychiatry 4, no. 2 (2017): 117-126.

Onaolapo, A. Y., and O. J. Onaolapo. "Schizophrenia aetiology and drug therapy: A tale of progressive demystification and strides in management." Adv Pharmacol Pharm 6, no. 2 (2018): 19-42.